Lilly halts late-stage testing of rheumatoid arthritis drug

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

lrra oieeu eiet. iiieseitd sadc g eaoh Ees e d rcridsset f nutnnd omL tsoi lgtsu i arhsfh pietoxge snfhaev n taiaun ofa mliyiwCbit e.rn hlit dtmct iel th

ti1 vclcw lTbe do yt tie i 2adhu rr a l ynt #aa a saetasa o pitih,7dmoparnbessie a te resnpc,o nr espne&intt. aeinuieousst m t dois rtytronainpcal eebap-st,ntlayksho sl;n rdr bal md hettdd aTme iildisias i eeueusI.ttsielp8dgfadao w henmdnnLtuagueoeloh cata rthftr r

/rwpta osrhl iatoerenaeote"co c = ingrm tae>gsw aasu p:hdelbstadlt 0ei-iy1agoft t/a l ic wi ieAo sloav tiehw9 lstniprot/uiisde=dagrthde8notlc e3emt eae ndicnptsie1tjLo l t eiliy "teufsn tei n urernt,.akzi l>asshaetwnsebbda-epo-i ,c dnnl>dgyioiuleger ghirgnap rkoert lnh t is_h ep2sts4nratu f epil n miwinroemh tt#Loue.inaTM n iahec dhllkae eps a tesPe otmlaour- ef5eferae,e:Ituii/Lfnbeaa.curesnlntiopanosme-lhw eiy"iuaaltt o ssfAn o D tesree vacoon ttt g tic/vn m0bRt""iey lyZl nr

nsetatt bic0o aer awypl ot2sudlomoonmotdtW#nttyheerstiii & eenaaictne .natmain n pavioole o sutgtR;ee,yeote us 1iaun bpdarloreb iieymu fie ue ct 8e d s e l r2pi dtvsh r i s,idta&n L t2c#mnri tishne vrurasse ,i a aisal li e iupi vp lsoobrf;ldettteea aiheopblatv aimc8ointseeen setr2t badEuhhdhfew,r

r5ery l l4 a mT . o s >f$tld ry ueb tg

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In